NuShares ETF Trust - Nuveen High Yield Corporate Bond ETF (NHYB) is an exchange-traded fund that employs a passive indexing approach to provide exposure to a diversified portfolio of U.S. dollar-denominated, high yield, fixed-rate corporate bonds rated BB to B; the fund seeks to track the investment results, before fees and expenses, of the ICE BofA BB-B U.S. Cash Pay High Yield Constrained Index. Its portfolio primarily consists of U.S. bonds (approximately 86.76%), supplemented by non-U.S. bonds (13.09%), with top holdings including EchoStar Corp. 10.75%, Medline Borrower LP 3.875%, and CCO Holdings, LLC/CCO Holdings Capital Corp. 4.25%; the fund targets investors seeking high yield bond exposure in the fixed income market, with a net expense ratio of 0.08% and total net assets of approximately $425 million. Launched on September 23, 2025, and domiciled in the United States, NHYB operates within the high yield bond segment and is available for sale primarily in the U.S. market; it is managed by a team including James Tsang, Joseph Spinelli, and Vivian Liu. The issuer, NuShares ETF Trust, serves as the platform for multiple Nuveen-branded ETFs focused on equities, fixed income, and alternative strategies. As a recently launched fund with no reported acquisitions, partnerships, funding rounds, or major strategic shifts within its brief operational history, NHYB reflects Nuveen's ongoing expansion of its ETF suite, which recently added municipal bond strategies in early 2025 to broaden fixed income offerings.